表 3.
FANCB基因rs754552650与肺癌风险相关性的分层分析
Stratified analyses of FANCB (rs754552650) for association with lung cancer risk
| Variable | Control group (n=445) | Case group (n=270) | OR (95%CI) | P |
| In the pathological type stratified analysis, the pathological type of the case group was compared with the control group as a whole. | ||||
| Age | ||||
| ≤60 yr | ||||
| AA | 93 (20.9%) | 94 (34.8%) | 1 | |
| A/G | 176 (39.6%) | 8 (3.0%) | 0.045 (0.021-0.097) | < 0.001 |
| GG | 69 (15.5%) | 0 (0%) | ||
| > 60 yr | ||||
| AA | 28 (6.3%) | 159 (58.9%) | 1 | |
| A/G | 58 (13.0%) | 9 (3.3%) | 0.027 (0.012-0.061) | < 0.001 |
| GG | 21 (4.7%) | 0 (0%) | ||
| Gender | ||||
| Female | ||||
| AA | 62 (13.9%) | 111 (41.1%) | 1 | |
| A/G | 130 (29.2%) | 15 (5.6%) | 0.064 (0.035-0.120) | < 0.001 |
| GG | 51 (11.4%) | 0 (0%) | ||
| Male | ||||
| AA | 59 (13.3%) | 142 (52.6%) | 1 | |
| A/G | 104 (23.4%) | 2 (0.7%) | 0.008 (0.002-0.033) | < 0.001 |
| GG | 39 (8.8%) | 0 (0%) | ||
| Histological type | ||||
| ADC | ||||
| AA | 121 (27.2%) | 183 (67.8%) | 1 | |
| A/G | 324 (72.8%) | 17 (6.3%) | 0.249 (0.145-0.426) | < 0.001 |
| SCC | ||||
| AA | 121 (27.2%) | 46 (17.0%) | ||
| A/G | 324 (72.8%) | 0 (0%) | ||
| ASC | ||||
| AA | 121 (27.2%) | 3 (1.1%) | ||
| A/G | 324 (72.8%) | 0 (0%) | ||
| SCLC | ||||
| AA | 121 (27.2%) | 15 (5.6%) | ||
| A/G | 324 (72.8%) | 0 (0%) | ||
| Others | ||||
| AA | 121 (27.2%) | 6 (2.2%) | ||
| A/G | 324 (72.8%) | 0 (0%) | ||